17.74
1.44%
-0.26
アフターアワーズ:
17.75
0.01
+0.06%
Bausch Lomb Corp (BLCO) 最新ニュース
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Ocular Prosthesis Market Trends, Challenges and Opportunities to 2030: A Projected $2.3 Billion Landscape - GlobeNewswire Inc.
Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer - Yahoo Finance
Bausch + Lomb down after report that Blackstone could back away from takeover bid - MSN
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Y Intercept Hong Kong Ltd Makes New Investment in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Short Interest in Bausch + Lomb Co. (NYSE:BLCO) Rises By 11.7% - MarketBeat
Janus Henderson Group PLC Purchases New Shares in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Bausch And Lomb Says Potential Sale In The Works - Law360
Bausch + Lomb exploring several options including a potential sale - Coast Reporter
Contact lens maker Bausch + Lomb says it is exploring sale - Reuters
Bausch + Lomb confirms it is exploring a potential sale - Financial Post
Bausch + Lomb responds to rumors of potential sale - Rochester Business Journal
Bausch + Lomb explores potential sale amid market rumors - Investing.com
Bausch + Lomb confirms board mulling sale of the company that would separate it from parent - MarketWatch
Bausch + Lomb explores sale amid separation plans - Investing.com
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb - Jonesboro Sun
Bausch + Lomb Responds to Rumors of a Potential Sale - Business Wire
Eye health company Bausch + Lomb’s affiliate acquires Elios Vision - Yahoo Finance
Bausch & Lomb: Key Partner in Joint Takeover's Interest Reportedly Cools, Spooking Investors - Morningstar
King Street Capital Management L.P. Buys New Stake in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Bausch + Lomb acquires glaucoma surgery innovator - Investing.com
S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities - Business Wire
Quadrature Capital Ltd Takes Position in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
大文字化:
|
ボリューム (24 時間):